Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.47 |
| ▸ | PDK2 | Q15119 | 10/20 | 0.44 |
| ▸ | HPGD | P15428 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18235863 | 0.91 | PDK2 (0.45) | APEX1PDK2SMN1; SMN2L3MBTL1MAPT | |
| SCHEMBL28228075 | 0.87 | HSD17B3 (0.47) | APEX1PDK2L3MBTL1HSD17B3ALDH1A1 | |
| SCHEMBL28228004 | 0.87 | HSD17B3 (0.47) | APEX1PDK2L3MBTL1HSD17B3ALDH1A1 | |
| SCHEMBL16550638 | 0.86 | PDK2 (0.53) | APEX1PDK2RAB9AMAPTNPC1 | |
| SCHEMBL28403051 | 0.84 | PDK2 (0.41) | APEX1PDK2 | |
| SCHEMBL18812919 | 0.84 | APEX1 (0.54) | APEX1PDK2HPGDSMN1; SMN2L3MBTL1 | |
| SCHEMBL25213695 | 0.84 | APEX1 (0.43) | APEX1PDK2HPGDSMN1; SMN2L3MBTL1 | |
| SCHEMBL4822886 | 0.83 | PDK2 (0.43) | APEX1PDK2 | |
| SCHEMBL22462062 | 0.83 | PDK2 (0.43) | APEX1PDK2 | |
| SCHEMBL14768863 | 0.83 | PDK2 (0.45) | APEX1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11118065-B2 | Fluorenylaminoketone photoinitiator, preparation method thereof, and UV photocurable composition containing same | TRPA1, TYR, PKLR | APEX1 3229/4885PDK2 58/4885HPGD 2219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.